Answers are grounded in this paper and cite their sources.
Provides a historical overview and description of the development and clinical application of percutaneous transluminal coronary angioplasty.
The nonsurgical treatment of arteries narrowed by atherosclerosis was introduced in 1964, when Dotter and Judkins performed transluminal angioplasty of femoral arterial stenoses1. In the 1970s, Gruntzig modified the dilation catheter to allow its use in coronary arteries,2 and in September 1977 he performed the first percutaneous transluminal coronary angioplasty (PTCA) in a patient. PTCA has since been used in many patients with stable angina, unstable angina, or acute myocardial infarction. Its use was initially limited to the treatment of discrete stenoses in proximal segments of a coronary artery, but improvements in equipment and technique have led to its . . .
No takes yet. Share an insight, caveat, or question.
Lange et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: